Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region

Acta Oncologica

Volumn 24, Issue 6, 1985, Pages 487-489

  Parvinen, L M ^a   Parvinen, M ^a   Nordman, E ^a   Kortekangas, A E ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COBALT 60;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG THERAPY; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARYNX; MOUTH; MUCOSA INFLAMMATION; PHARYNX; PRIORITY JOURNAL; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; THERAPY;

EID: 84907108862     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841868509134421     Document Type: Article

References (11)

1. The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture
2. Bleomycin. A review
3. 2 on Novikoff hepatoma ascites cells
4. The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy
5. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma. A controlled clinical study
6. Experience with preoperative irradiation in head and neck cancer
7. Tumour regression during radiation treatment as a guide to prognosis
8. Bleomycin as adjuvant in radiation therapy of advanced squamous cell carcinoma in head and neck
9. Prognostic significance of extent of tumour regression at completion of radiation therapy
10. Chemistry and mechanism of action of bleomycin
11. Response in macromolecular synthesis of mouse L cells to bfeomycin, with special reference to cell-antibiotic interaction